This case series presents the use of elamipretide in two patients with different progressive mitochondrial disorders (chronic progressive external ophthalmoplegia [CPEO] plus and neuropathy, ataxia, and retinitis pigmentosa [NARP] syndrome) characterized by ophthalmic traits. Elamipretide was well tolerated and both patients demonstrated improvement in symptoms while on therapy.
Keywords: CPEO; Cardiolipin; Elamipretide; NARP syndrome; mitochondrial disease.
© 2024 The Author(s). Clinical Case Reports published by John Wiley & Sons Ltd.